The motion: PDE5 inhibitors will have a significant role in the treatment of BPH

被引：6
作者：
Kaplan, Steven A. [1 ]
机构：
[1] Cornell Univ, Weill Cornell Med Coll, Inst Bladder & Prostate Hlth, New York, NY 10021 USA
[2] Aristotle Univ Thessaloniki, Dept Urol 2, Papageorgiou Gen Hosp, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Ctr Sexual & Reprod Hlth, GR-54006 Thessaloniki, Greece
来源：
EUROPEAN UROLOGY | 2007年 / 52卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2007.08.025
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1523 / 1527
页数：5
相关论文
共 19 条
  • [1] Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence
    Andersson, KE
    Wein, AJ
    [J]. PHARMACOLOGICAL REVIEWS, 2004, 56 (04) : 581 - 631
  • [2] The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis
    Blake-James, Benedict T.
    Rashidian, Arash
    Ikeda, Youko
    Emberton, Mark
    [J]. BJU INTERNATIONAL, 2007, 99 (01) : 85 - 96
  • [3] Results of double-blind placebo-controlled crossover study of sildenafil citrate (viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation (Fowler's syndrome)
    Datta, Soumendra N.
    Kavia, Rajesh B. C.
    Gonzales, Gwen
    Fowler, Clare J.
    [J]. EUROPEAN UROLOGY, 2007, 51 (02) : 489 - 497
  • [4] Characterization and functional role of androgen-dependent PDE5 activity in the bladder
    Filippi, Sandra
    Morelli, Annamaria
    Sandner, Peter
    Fibbi, Benedetta
    Mancina, Rosa
    Marini, Mirca
    Gacci, Mauro
    Vignozzi, Linda
    Vannelli, Gabriella Barbara
    Carini, Marco
    Forti, Gianni
    Maggi, Mario
    [J]. ENDOCRINOLOGY, 2007, 148 (03) : 1019 - 1029
  • [5] Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Gonzalez, Ricardo R.
    Kaplan, Steven A.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 609 - 617
  • [6] Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction
    Kaplan, Steven A.
    Gonzalez, Ricardo R.
    Te, Alexis E.
    [J]. EUROPEAN UROLOGY, 2007, 51 (06) : 1717 - 1723
  • [7] Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder - A randomized controlled trial
    Kaplan, Steven A.
    Roehrborn, Claus G.
    Rovner, Eric S.
    Carlsson, Martin
    Bavendam, Tamara
    Guan, Zhonghong
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (19): : 2319 - 2328
  • [8] Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
    Kramer, Gero
    Mitteregger, Dieter
    Marberger, Michael
    [J]. EUROPEAN UROLOGY, 2007, 51 (05) : 1202 - 1216
  • [9] The long-term outcome of medical therapy for BPH
    Madersbacher, Stephan
    Marszalek, Martin
    Lackner, Jakob
    Berger, Peter
    Schatzl, Georg
    [J]. EUROPEAN UROLOGY, 2007, 51 (06) : 1522 - 1533
  • [10] Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology
    McVary, K
    [J]. BJU INTERNATIONAL, 2006, 97 : 23 - 28
12